Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Ermenegildo Zegna NV
ZGN
5
Precision Drilling
PDS
US Stock MarketDetailed Quotes
SUPN Supernus Pharmaceuticals
- 31.540
- +0.600+1.94%
Close May 8 16:00 ET
- 31.540
- 0.0000.00%
Post 16:05 ET
1.77BMarket Cap28.47P/E (TTM)
31.910High30.440Low421.01KVolume30.830Open30.940Pre Close13.24MTurnover0.87%Turnover Ratio23.89P/E (Static)55.99MShares40.28052wk High1.71P/B1.53BFloat Cap25.53052wk Low--Dividend TTM48.66MShs Float61.250Historical High--Div YieldTTM4.75%Amplitude4.300Historical Low31.447Avg Price1Lot Size
Supernus Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 55.71%463.59M | 77.97%453.61M | 77.97%453.61M | 101.41%403.21M | 128.93%347.19M | 30.26%297.74M | -44.75%254.87M | -44.75%254.87M | -48.90%200.19M | -57.97%151.66M |
| -Cash and cash equivalents | 82.72%115.85M | -7.63%69.33M | -7.63%69.33M | -66.65%31.67M | 110.84%52.09M | 8.49%63.4M | -19.40%75.05M | -19.40%75.05M | -14.81%94.99M | -85.75%24.71M |
| -Short-term investments | 48.40%347.74M | 113.70%384.28M | 113.70%384.28M | 253.16%371.54M | 132.45%295.1M | 37.74%234.34M | -51.16%179.82M | -51.16%179.82M | -62.47%105.2M | -32.24%126.95M |
| Receivables | -1.42%145.64M | -1.44%142.08M | -1.44%142.08M | 2.57%145.41M | 11.67%152.49M | 2.90%147.73M | -12.90%144.16M | -12.90%144.16M | -13.60%141.76M | -13.61%136.56M |
| -Accounts receivable | -1.42%145.64M | -1.44%142.08M | -1.44%142.08M | 2.57%145.41M | 11.67%152.49M | 2.90%147.73M | -12.90%144.16M | -12.90%144.16M | -13.60%141.76M | -13.61%136.56M |
| Inventory | -34.17%49.42M | -29.86%54.29M | -29.86%54.29M | -23.36%63.98M | -24.74%68.16M | -17.63%75.08M | -15.44%77.41M | -15.44%77.41M | 0.38%83.48M | 6.72%90.56M |
| Other current assets | 21.70%28.93M | 116.41%36.09M | 116.41%36.09M | 14.53%27.4M | -48.25%23.17M | 45.85%23.77M | 5.68%16.68M | 5.68%16.68M | -3.70%23.93M | 109.09%44.77M |
| Total current assets | 26.32%687.58M | 39.13%686.07M | 39.13%686.07M | 42.43%640M | 39.54%591M | -38.38%544.32M | -32.83%493.11M | -32.83%493.11M | -32.31%449.36M | -32.25%423.54M |
| Non current assets | ||||||||||
| Net PPE | -12.58%11.34M | -14.67%11.55M | -14.67%11.55M | -13.24%11.88M | -13.48%12.27M | -11.24%12.97M | -10.83%13.53M | -10.83%13.53M | -13.76%13.69M | -13.06%14.19M |
| -Gross PPE | 2.73%29.78M | 1.57%29.39M | 1.57%29.39M | 1.79%29.12M | 1.45%28.9M | 2.44%28.99M | 2.53%28.94M | 2.53%28.94M | -0.72%28.6M | -0.13%28.49M |
| -Accumulated depreciation | -15.13%-18.44M | -15.83%-17.84M | -15.83%-17.84M | -15.59%-17.24M | -16.26%-16.63M | -17.05%-16.02M | -18.06%-15.41M | -18.06%-15.41M | -15.29%-14.92M | -17.15%-14.3M |
| Goodwill and other intangible assets | -11.14%619.15M | -10.88%638.93M | -10.88%638.93M | -13.32%657.18M | -13.18%676.66M | -12.85%696.77M | -12.52%716.91M | -12.52%716.91M | -9.76%758.17M | -9.25%779.41M |
| -Goodwill | 0.00%117.02M | 0.00%117.02M | 0.00%117.02M | 0.00%117.02M | 0.00%117.02M | 0.00%117.02M | 0.00%117.02M | 0.00%117.02M | -0.31%117.02M | 1.39%117.02M |
| -Other intangible assets | -13.39%502.13M | -13.00%521.91M | -13.00%521.91M | -15.75%540.16M | -15.51%559.64M | -15.05%579.75M | -14.60%599.89M | -14.60%599.89M | -11.29%641.15M | -10.90%662.39M |
| Investments and advances | ---- | --0 | --0 | --0 | --0 | -78.47%11.66M | -82.30%16.62M | -82.30%16.62M | -80.96%25.13M | -74.57%37.48M |
| Other non current assets | -23.83%29.22M | -15.94%31.53M | -15.94%31.53M | -13.33%33.65M | -6.75%35.89M | -4.52%38.37M | -5.78%37.51M | -5.78%37.51M | -5.98%38.82M | -18.70%38.49M |
| Total non current assets | -13.17%659.71M | -13.07%682M | -13.07%682M | -15.93%702.7M | -16.64%724.83M | -16.37%759.77M | -18.98%784.56M | -18.98%784.56M | -18.79%835.8M | -18.72%869.56M |
| Total assets | 3.31%1.35B | 7.08%1.37B | 7.08%1.37B | 4.48%1.34B | 1.76%1.32B | -27.22%1.3B | -24.95%1.28B | -24.95%1.28B | -24.10%1.29B | -23.71%1.29B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -50.88%7.07M | 133.55%4.59M | 133.55%4.59M | 88.61%6.39M | 5.18%4.63M | 24.71%14.4M | -81.37%1.96M | -81.37%1.96M | -78.84%3.39M | -87.61%4.4M |
| -accounts payable | -50.88%7.07M | 133.55%4.59M | 133.55%4.59M | 88.61%6.39M | 5.18%4.63M | 24.71%14.4M | -81.37%1.96M | -81.37%1.96M | -78.84%3.39M | -87.61%4.4M |
| Current accrued expenses | 1.29%216.42M | 4.70%212.36M | 4.70%212.36M | -0.49%209.02M | 11.10%226.38M | 1.91%213.65M | -5.09%202.83M | -5.09%202.83M | -8.38%210.05M | -8.07%203.77M |
| Current debt and capital lease obligation | -34.99%5.94M | -17.31%6.89M | -17.31%6.89M | 8.81%9.23M | 20.75%9.68M | -98.13%9.13M | -97.96%8.33M | -97.96%8.33M | -97.92%8.48M | -98.03%8.02M |
| -Current capital lease obligation | -34.99%5.94M | -17.31%6.89M | -17.31%6.89M | 8.81%9.23M | 20.75%9.68M | 20.55%9.13M | 22.68%8.33M | 22.68%8.33M | 25.50%8.48M | 13.91%8.02M |
| Other current liabilities | -42.97%34.75M | -15.99%47.34M | -15.99%47.34M | -0.02%46.58M | 145.78%50.93M | 713.97%60.93M | 48.36%56.35M | 48.36%56.35M | -16.47%46.59M | -62.91%20.72M |
| Current liabilities | -10.42%281.77M | 0.76%292.4M | 0.76%292.4M | 1.38%291.51M | 22.20%308.66M | -57.00%314.55M | -57.82%290.2M | -57.82%290.2M | -60.39%287.53M | -65.66%252.59M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -20.08%26.37M | -17.51%27.38M | -17.51%27.38M | -14.52%28.93M | -11.36%30.29M | -9.63%32.99M | -7.78%33.2M | -7.78%33.2M | -6.07%33.84M | -7.83%34.18M |
| -Long term capital lease obligation | -20.08%26.37M | -17.51%27.38M | -17.51%27.38M | -14.52%28.93M | -11.36%30.29M | -9.63%32.99M | -7.78%33.2M | -7.78%33.2M | -6.07%33.84M | -7.83%34.18M |
| Non current deferred liabilities | -94.97%981K | -80.13%4.96M | -80.13%4.96M | -79.09%7.36M | -74.18%11.44M | -60.74%19.5M | -49.88%24.96M | -49.88%24.96M | -39.44%35.22M | -25.31%44.3M |
| Other non current liabilities | -5.22%7.46M | -2.59%7.6M | -2.59%7.6M | -52.64%7.75M | -81.04%7.99M | -87.28%7.88M | -81.66%7.8M | -81.66%7.8M | -18.77%16.37M | 94.93%42.12M |
| Total non current liabilities | -42.33%34.81M | -39.44%39.94M | -39.44%39.94M | -48.45%44.04M | -58.77%49.72M | -59.24%60.37M | -48.61%65.96M | -48.61%65.96M | -25.28%85.44M | 2.20%120.6M |
| Total liabilities | -15.56%316.59M | -6.69%332.34M | -6.69%332.34M | -10.03%335.55M | -3.97%358.38M | -57.38%374.92M | -56.37%356.16M | -56.37%356.16M | -55.62%372.97M | -56.28%373.19M |
| Shareholders'equity | ||||||||||
| Share capital | 1.82%56K | 1.82%56K | 1.82%56K | 0.00%55K | 0.00%55K | 1.85%55K | 1.85%55K | 1.85%55K | 1.85%55K | 3.77%55K |
| -common stock | 1.82%56K | 1.82%56K | 1.82%56K | 0.00%55K | 0.00%55K | 1.85%55K | 1.85%55K | 1.85%55K | 1.85%55K | 3.77%55K |
| Retained earnings | 12.83%544.6M | 15.31%556.43M | 15.31%556.43M | 12.40%541.1M | 1.05%502.6M | -3.11%482.69M | 0.27%482.56M | 0.27%482.56M | 5.62%481.39M | 9.55%497.36M |
| Paid-in capital | 8.78%486.21M | 9.09%479.44M | 9.09%479.44M | 7.86%465.92M | 7.28%455.17M | 7.38%446.96M | 7.69%439.49M | 7.69%439.49M | 7.71%431.96M | 8.90%424.27M |
| Gains losses not affecting retained earnings | 70.22%-159K | 68.13%-189K | 68.13%-189K | 106.47%78K | 79.04%-372K | 77.07%-534K | 81.53%-593K | 81.53%-593K | 70.19%-1.21M | 20.05%-1.78M |
| Total stockholders'equity | 10.93%1.03B | 12.39%1.04B | 12.39%1.04B | 10.41%1.01B | 4.08%957.45M | 1.87%929.17M | 3.98%921.52M | 3.98%921.52M | 6.96%912.19M | 9.33%919.91M |
| Total equity | 10.93%1.03B | 12.39%1.04B | 12.39%1.04B | 10.41%1.01B | 4.08%957.45M | 1.87%929.17M | 3.98%921.52M | 3.98%921.52M | 6.96%912.19M | 9.33%919.91M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now